First Anniversary Milestones and Future Plans WHAT: An update on the Product Quality Research Institute’s (PQRI) key events and milestones in its first year and future plans. Learn about the first three research projects that PQRI has adopted to undertake, the fundraising effort underway to support the research projects, and FDA’s support for the initiative.

Speakers include:
· John B. Cox, Executive Director, American Association of Pharmaceutical Scientists (AAPS)
· Helen Winkle, Acting Director, Office of Pharmaceutical Sciences, FDA
· Kenneth Heimlich, Ph.D., Chair, PQRI Board of Directors
· Tobias Massa, Ph.D., Chair, PQRI Steering Committee

WHERE:
National Press Club, First Amendment Room
529 14th Street, NW
Washington, DC

WHEN:
Tuesday, December 12 at 10:00 a.m.

CONTACT:
Debbie Werfel at 703-248-4743,
[email protected]
Jim Greif at 703-248-4744,
[email protected]

About PQRI
The Product Quality Research Institute (PQRI) is a collaborative effort by FDA’s Center for Drug Evaluation and Research (CDER), industry and academia to examine and support drug regulatory issues. PQRI’s research projects will generate scientific support to reduce regulatory testing and reporting requirements without compromising drug product quality. The institute’s recommendations based on this research are expected to speed new drug approvals and reduce the industry's cost for pharmaceutical development. For additional information about PQRI, visit www.pqri.org.

About AAPS
PQRI is administratively managed by AAPS. AAPS is a professional, scientific society of more than 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource, and contribute to human health through pharmaceutical research and development. For more information about AAPS, visit AAPS Pharmaceutica at www.aapspharmaceutica.com .